Bioactive compounds as therapeutic modulators of metabolic syndrome: targeting inflammation and gut microbiota regulation.
- DOI
- 10.3389/fphys.2026.1766078
- Published
- 2026
- Container
- Frontiers in physiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphys.2026.1766078,
title = {Bioactive compounds as therapeutic modulators of metabolic syndrome: targeting inflammation and gut microbiota regulation.},
author = {Udobi ME and Bella-Omunagbe M and Afolabi IS and Chinedu SN},
year = {2026},
journal = {Frontiers in physiology},
doi = {10.3389/fphys.2026.1766078},
url = {https://doi.org/10.3389/fphys.2026.1766078}
}RIS
TY - JOUR TI - Bioactive compounds as therapeutic modulators of metabolic syndrome: targeting inflammation and gut microbiota regulation. AU - Udobi ME AU - Bella-Omunagbe M AU - Afolabi IS AU - Chinedu SN PY - 2026 JO - Frontiers in physiology DO - 10.3389/fphys.2026.1766078 UR - https://doi.org/10.3389/fphys.2026.1766078 ER -
APA
ME, U., M, B., IS, A., & SN, C. (2026). Bioactive compounds as therapeutic modulators of metabolic syndrome: targeting inflammation and gut microbiota regulation.. Frontiers in physiology. https://doi.org/10.3389/fphys.2026.1766078
Source records
- pubmed · retrieved 2026-09-24T23:51:02.889Z